Statizoid

Central African Republic vs Dominican Republic: Antiretroviral therapy coverage for PMTCT

Central African Republic
69.0%
in 2024
Dominican Republic
68.0%
in 2024
Central African Republic rank
52nd
Dominican Republic rank
54th

Antiretroviral therapy coverage for PMTCT over time

  • Central African Republic
  • Dominican Republic
0204060200020122024

How they compare

Central African Republic currently reports 69.0% against 68.0% in Dominican Republic, a difference of 1.0%.

The two have swapped places 5 times across 25 shared years of data; in 2000 it was Dominican Republic ahead.

Central African Republic ranks 52nd and Dominican Republic ranks 54th of 84 countries.

Across the 3 decades both report, Central African Republic averaged higher in 2 and Dominican Republic in 1.

Head to head by decade

Decade Central African Republic Dominican Republic Difference Ahead
2000s 9.0% 16.8% 7.8% Dominican Republic
2010s 40.7% 37.7% 3.0% Central African Republic
2020s 59.2% 49.8% 9.4% Central African Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage for pmtct, Central African Republic or Dominican Republic?
Central African Republic, at 69.0% against 68.0% in Dominican Republic as of 2024.
What is the difference in antiretroviral therapy coverage for pmtct between Central African Republic and Dominican Republic?
1.0%, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and Dominican Republic?
25 years are reported by both, from 2000 to 2024.
How do Central African Republic and Dominican Republic rank globally for antiretroviral therapy coverage for pmtct?
Central African Republic ranks 52nd and Dominican Republic ranks 54th of 84 countries.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Dominican Republic: Antiretroviral therapy coverage for PMTCT. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/central-african-republic/dominican-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/central-african-republic/dominican-republic/">Central African Republic vs Dominican Republic: Antiretroviral therapy coverage for PMTCT</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).